<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Virbac Sa — News on 6ix</title>
<link>https://6ix.com/company/virbac-sa-1</link>
<description>Latest news and press releases for Virbac Sa on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Apr 2026 18:40:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/virbac-sa-1" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d53914beedb30cb6f70079.webp</url>
<title>Virbac Sa</title>
<link>https://6ix.com/company/virbac-sa-1</link>
</image>
<item>
<title>Leading with Care: Virbac Becomes a Human-Animal Bond Certified Company</title>
<link>https://6ix.com/company/virbac-sa-1/news/leading-with-care-virbac-becomes-a-human-animal-bond-certified-company-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/leading-with-care-virbac-becomes-a-human-animal-bond-certified-company-1</guid>
<pubDate>Wed, 22 Apr 2026 18:40:00 GMT</pubDate>
<description>The North American Veterinary Community (NAVC) and the Human Animal Bond Research Institute (HABRI) today announced that Virbac Corporation (Virbac) has become Human-Animal Bond Certified, making a major commitment to training and education and expanding its partnership with HABRI, announced earlier this year. The Human-Animal Bond Certification, created by HABRI and the NAVC, provides a deeper understanding of the health benefits of pet ownership and human-animal interaction and how this inform</description>
</item>
<item>
<title>Virbac: strong Q1 2026 growth of +7.7% at CERS, driven by double-digit growth of our priority Supercharge4 platforms</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-strong-q1-2026-growth-of-77percent-at-cers-driven-by-double-digit-growth-of-our-priority-supercharge4-platforms-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-strong-q1-2026-growth-of-77percent-at-cers-driven-by-double-digit-growth-of-our-priority-supercharge4-platforms-1</guid>
<pubDate>Thu, 16 Apr 2026 15:45:00 GMT</pubDate>
<description>First-quarter 2026 revenue reached €384m : +7.7% at constant exchange rate and scope (CERS) vs Q1 2025+2.2% at actual rates impacted by significant currency headwinds Balanced growth in both segments : companion animal +9.9% and farm animal +8.4% with a strong contribution from our Supercharge platforms (excl. Thyronorm) with an increase of around +15% at CERS.Solid volume/mix effect of ~+6%, completed by price increase of ~+2%Excellent Q1 2026 performance driven by exceptional growth in North A</description>
</item>
<item>
<title>Virbac : Declaration of the number of shares and voting rights 03/2026</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-032026-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-032026-1</guid>
<pubDate>Tue, 07 Apr 2026 09:06:00 GMT</pubDate>
<description>DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsMarch, 31 20268 390 660Gross total of voting rights : 12 707 254Net total* of</description>
</item>
<item>
<title>Virbac: 2025 annual results</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-2025-annual-results-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-2025-annual-results-1</guid>
<pubDate>Tue, 17 Mar 2026 16:45:00 GMT</pubDate>
<description>A robust adjusted EBIT margin² of 16.3% at CERS, driven by solid organic revenue growth of 7.9% Solid 2025 dynamic with annual revenue up +7.9% at CERS; with strong momentum in key categories and countries. Volume/mix effect of ~+5%, completed by price increase of ~+3%Adjusted EBIT (before amortization of assets arising from acquisitions) margin of 16.3% at CERS despite: temporary shutdown of an antigen’s production site and higher inventory write-offs in FY25partially offset by a solid underlyi</description>
</item>
<item>
<title>Virbac : Declaration of the number of shares and voting rights 02/2026</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-022026-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-022026-1</guid>
<pubDate>Tue, 10 Mar 2026 17:10:00 GMT</pubDate>
<description>DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsFebruary, 28 20268 390 660Gross total of voting rights : 12 703 749Net total*</description>
</item>
<item>
<title>Virbac : Declaration of the number of shares and voting rights 01/2026</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-012026-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-012026-1</guid>
<pubDate>Thu, 05 Feb 2026 16:29:00 GMT</pubDate>
<description>DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsJanuary, 31 20268 390 660Gross total of voting rights : 12 704 131Net total* o</description>
</item>
<item>
<title>Virbac: solid 2025 dynamic with annual revenue up +7.9% at CERS3; with strong momentum in key categories and countries</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-solid-2025-dynamic-with-annual-revenue-up-79percent-at-cers3-with-strong-momentum-in-key-categories-and-countries-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-solid-2025-dynamic-with-annual-revenue-up-79percent-at-cers3-with-strong-momentum-in-key-categories-and-countries-1</guid>
<pubDate>Mon, 19 Jan 2026 16:45:00 GMT</pubDate>
<description>Full-year 2025 revenue reached €1,465m : +7.9% at constant exchange rate and scope (CERS) vs 2024+4.8% at actual rates impacted by significant currency headwinds, particularly in Latin America, IMEA and the Pacific. Strong companion animal growth of +10.9% and farm animal of +6.1% at CERS Solid volume/mix effect of ~+5%, completed by price increase of ~+3%Excellent performance in 2025 in the USA (+14.7% at CERS), followed by IMEA (+9.5%), Latin America (+7.5%) and Europe (+7.5%). Sustained growt</description>
</item>
<item>
<title>Virbac : Declaration of the number of shares and voting rights 12/2025</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-122025-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-122025-1</guid>
<pubDate>Fri, 09 Jan 2026 17:06:00 GMT</pubDate>
<description>DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsDecember, 31 20258 390 660Gross total of voting rights : 12 704 596Net total*</description>
</item>
<item>
<title>VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-feline-hyperthyroidism-virbac-acquires-thyronorm-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-feline-hyperthyroidism-virbac-acquires-thyronorm-1</guid>
<pubDate>Tue, 16 Dec 2025 08:53:00 GMT</pubDate>
<description>Acquisition provides Virbac with a leading specialty product, in a growing segment, to improve the quality of life for senior cats.We are delighted to announce the acquisition of an innovative drug from Norbrook to stabilize feline hyperthyroidism. Virbac will ensure the direct distribution of this treatment under the Thyronorm brand in the United Kingdom, Australia, and New Zealand, and under the Felanorm brand in the United States. In Europe, distribution will continue to be managed by Boehrin</description>
</item>
<item>
<title>Virbac : Declaration of the number of shares and voting rights 11/2025</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-112025-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-112025-1</guid>
<pubDate>Mon, 08 Dec 2025 09:13:00 GMT</pubDate>
<description>DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsNovember, 30 20258 390 660Gross total of voting rights : 12 704 542Net total* of</description>
</item>
<item>
<title>Virbac : Declaration of the number of shares and voting rights 10/2025</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-102025-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-102025-1</guid>
<pubDate>Fri, 07 Nov 2025 14:40:00 GMT</pubDate>
<description>DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsOctober, 31 20258 390 660Gross total of voting rights : 12 704 809Net total* of</description>
</item>
<item>
<title>VIRBAC Announces Third Quarter 2025 Sales</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-announces-third-quarter-2025-sales-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-announces-third-quarter-2025-sales-1</guid>
<pubDate>Thu, 16 Oct 2025 15:45:00 GMT</pubDate>
<description>Sustained revenue growth at the end of September of +7.8% at constant exchange rates and scopeUpgrade of the full-year revenue guidance Revenue growth now expected to be between 5.5% and 7.5% at constant rates and scopeAdjusted recurring operating income¹ expected around 16% Press release on October 16, 2025, after market close at 5:45 p.m. CEST KEY FIGURES Revenue in first half of 2025 €1102.4M Growth at constant exchange rates and scope2 +7.8 including companion animals +11.3% farm animals +6.</description>
</item>
<item>
<title>Virbac : Declaration of the number of shares and voting rights 09/2025</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-092025-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-092025-1</guid>
<pubDate>Fri, 03 Oct 2025 14:56:00 GMT</pubDate>
<description>DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsSeptember, 30 20258 390 660Gross total of voting rights : 12 705 441Net total* o</description>
</item>
<item>
<title>Virbac: 2025 Half-year results</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-2025-half-year-results-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-2025-half-year-results-1</guid>
<pubDate>Fri, 12 Sep 2025 15:45:00 GMT</pubDate>
<description>Solid revenue growth in the first half of 2025 of +5.6% at constant exchange rates and scopeAdjusted recurring operating income² of 18.3% as a ratio to revenue, in line with our expectations Down compared to 2024 due to phasing and non-recurring effects 2025 targets confirmed Revenue growth expected between 4% and 6% at constant rates and scopeAdjusted recurring operating income¹ expected around 16% CONSOLIDATED FIGURES AS OF JUNE 30in € million HY25 HY24 Variance 2025/2024 Revenues 738.3 702.9</description>
</item>
<item>
<title>Virbac : Declaration of the number of shares and voting rights 08/2025</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-082025-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-082025-1</guid>
<pubDate>Fri, 05 Sep 2025 12:45:00 GMT</pubDate>
<description>DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsAugust, 31 20258 390 660Gross total of voting rights : 12 705 441Net total* of v</description>
</item>
<item>
<title>Virbac : Declaration of the number of shares and voting rights 07/2025</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-072025-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-072025-1</guid>
<pubDate>Fri, 05 Sep 2025 12:40:00 GMT</pubDate>
<description>DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsJuly, 31 20258 390 660Gross total of voting rights : 12 705 786Net total* of vot</description>
</item>
<item>
<title>Virbac:: Paul Martingell's compensation terms</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-paul-martingells-compensation-terms-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-paul-martingells-compensation-terms-1</guid>
<pubDate>Mon, 18 Aug 2025 07:30:00 GMT</pubDate>
<description>The board of directors of Virbac specifies Paul Martingell's compensation terms as chief executive officer. The board of directors, acting upon the recommendation of the appointments and compensation committee, has approved the compensation terms for Paul Martingell for the duration of his mandate, as detailed below. In accordance with applicable regulations, Paul Martingell's compensation elements will be submitted for the approval of the shareholders ("ex ante" and "ex post" votes). Fixed comp</description>
</item>
<item>
<title>Virbac: in the first half of 2025, revenue recorded solid growth of +5.6% at constant exchange rates and scope of consolidation</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-in-the-first-half-of-2025-revenue-recorded-solid-growth-of-56percent-at-constant-exchange-rates-and-scope-of-consolidation-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-in-the-first-half-of-2025-revenue-recorded-solid-growth-of-56percent-at-constant-exchange-rates-and-scope-of-consolidation-1</guid>
<pubDate>Wed, 16 Jul 2025 15:45:00 GMT</pubDate>
<description>KEY FIGURES Revenue in first half of 2025 €738.3M Growth at constant exchange rates and scope1 +5.6 including companion animals +7.1% farm animals +5.1% Growth at constant exchange rates2 +7.8% Overall change +5.0% Quarterly consolidated revenueOur second-quarter revenue reached €363.1 million, marking a +6.4% increase at constant exchange rates and scope compared to the same period in 2024. This strong quarterly performance demonstrates the resilience of our organic growth, observed across all</description>
</item>
<item>
<title>Virbac : Declaration of the number of shares and voting rights 06/2025</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-062025-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-declaration-of-the-number-of-shares-and-voting-rights-062025-1</guid>
<pubDate>Fri, 04 Jul 2025 10:04:00 GMT</pubDate>
<description>DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsJune, 30 20258 390 660Gross total of voting rights : 12 706 453Net total* of vot</description>
</item>
<item>
<title>VIRBAC: Paul Martingell is appointed chief executive officer of Virbac, effective September 1, 2025</title>
<link>https://6ix.com/company/virbac-sa-1/news/virbac-paul-martingell-is-appointed-chief-executive-officer-of-virbac-effective-september-1-2025-1</link>
<guid isPermaLink="true">https://6ix.com/company/virbac-sa-1/news/virbac-paul-martingell-is-appointed-chief-executive-officer-of-virbac-effective-september-1-2025-1</guid>
<pubDate>Thu, 19 Jun 2025 06:30:00 GMT</pubDate>
<description>Virbac announces the appointment of Paul Martingell as the chief executive officer of the Virbac group, effective September 1, 2025. Paul Martingell, 45, is recognized as a leader who has demonstrated his ability to engage and inspire international teams, manage complexity, and create value for all stakeholders. He holds an MBA with distinction in Mergers and Acquisitions and is a Chartered Accountant in the United Kingdom. He has over 25 years of extensive international experience, particularly</description>
</item>
</channel>
</rss>